Literature DB >> 19160364

Composite abdominosacral resection for recurrent rectal cancer.

P M Sagar1, S Gonsalves, R M Heath, N Phillips, A G Chalmers.   

Abstract

BACKGROUND: En bloc resection of the tumour and adjacent involved organs offers the only realistic curative option for patients with locally recurrent rectal cancer. This study assessed outcomes of composite resection for recurrent tumours involving the sacrum.
METHODS: A consecutive series of patients underwent composite abdominosacral resection (abdominal mobilization and stoma construction followed by sacral division and tumour retrieval) for recurrent rectal cancer between 2001 and 2007. Patients were staged with preoperative computed tomography, magnetic resonance imaging and positron emission tomography. Data were collected prospectively.
RESULTS: Forty patients (28 men; median age 59 (range 31-77) years) underwent surgery with sacral division at the S2/3 interface in 13, S3/4 level in 20 and S4/5 level in seven patients. One patient died and 24 had complications. An R0 resection was achieved in 20 patients and conferred benefit in disease-free interval over an R1 resection. The mean disease-free interval was 55.6 (95 per cent confidence interval (c.i.) 40.0 to 71.3) months for R0 and 32.2 (95 per cent c.i. 19.7 to 44.7) months for R1 resection (P = 0.048).
CONCLUSION: Composite abdominosacral resection of locally recurrent rectal cancer is an effective treatment for a difficult clinical scenario.

Entities:  

Mesh:

Year:  2009        PMID: 19160364     DOI: 10.1002/bjs.6464

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  11 in total

Review 1.  Surgery for recurrent rectal cancer: technical notes and management of complications.

Authors:  A H Mirnezami; P M Sagar
Journal:  Tech Coloproctol       Date:  2010-05-12       Impact factor: 3.781

2.  Factors associated with the location of local rectal cancer recurrence and predictors of survival.

Authors:  Peng Du; John P Burke; Wisam Khoury; Ian C Lavery; Ravi P Kiran; Feza H Remzi; David W Dietz
Journal:  Int J Colorectal Dis       Date:  2016-02-10       Impact factor: 2.571

3.  En Bloc Resection with Partial Sacrectomy Helps to Achieve R0 Resection in Locally Advanced Rectal Cancer, Experience from a Tertiary Cancer Center.

Authors:  Nizamudheen M Pareekutty; Satheesan Balasubramanian; Sachin Kadam; Dipin Jayaprakash; Basavaraj Ankalkoti; Sangeetha Nayanar; Geetha Muttath; Bindu Anilkumar
Journal:  Indian J Surg Oncol       Date:  2019-01-09

4.  Pelvic exenteration for advanced and recurrent malignancy.

Authors:  Evita Zoucas; Sven Frederiksen; Marie-Louise Lydrup; Wiking Månsson; Pelle Gustafson; Per Alberius
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 5.  Intentionally curative treatment of locally recurrent rectal cancer: a systematic review.

Authors:  Pieter J Tanis; Annemiek Doeksen; J Jan B van Lanschot
Journal:  Can J Surg       Date:  2013-04       Impact factor: 2.089

6.  Pelvic Exenteration for Locally Advanced and Relapsed Pelvic Malignancies - An Analysis of 100 Cases.

Authors:  Nicolae Bacalbasa; Adina Croitoru; Irina Balescu; Mihaela Vilcu; Adrian Neacsu; Simona Dima; Iulian Brezean
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

Review 7.  Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options.

Authors:  P A Georgiou; P P Tekkis; G Brown
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

Review 8.  Locally advanced rectal cancer: management challenges.

Authors:  R F Kokelaar; M D Evans; M Davies; D A Harris; J Beynon
Journal:  Onco Targets Ther       Date:  2016-10-13       Impact factor: 4.147

9.  Abdominosacral resection for locally recurring rectal cancer.

Authors:  Filiberto Belli; Alessandro Gronchi; Carlo Corbellini; Massimo Milione; Ermanno Leo
Journal:  World J Gastrointest Surg       Date:  2016-12-27

Review 10.  Advances in surgical management for locally recurrent rectal cancer: How far have we come?

Authors:  Daniel Jin-Keat Lee; Peter M Sagar; Gaitri Sadadcharam; Kok-Yang Tan
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.